Curating the latest ADC science, clinical data and lessons learned World ADC London will enable you to maximise the clinical therapeutic window of your ADC.
World ADC London is Europe’s leading antibody-drug conjugate conference. Across three days, this comprehensive three streamed programme will cover every element of ADCs from discovery, development, manufacturing and clinical.
Attend World ADC London to validate novel ADC targets, improve understanding of mechanisms driving toxicity in clinical development and robustly scale up process development to support commercialisation. 320 drug developers across 140+ active organisations will unite at this industry focussed conference to foster new connections, further develop business relationships and meet with current partners.
Join your peers at Europe’s longest standing and most comprehensive ADC conference to power the development of your ADC pipeline.